Delivery Order 75N91018D00023-75N91020F00001

Award Date 7/25/20
Potential Completion Date 7/6/25
Potential Value $12M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Chicago, IL 60637, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $8,241,552.00 Delivery Order awarded to the University of Chicago by the National Cancer Institute, a civilian agency within the federal government. The contract is part of a larger indefinite delivery vehicle called the "Cancer Study Cohort Recruitment" contract. The University of Chicago, a private research university, will provide services related to the "CONNECT TASK ORDER 8" requirement. This task order does not have a set-aside designation. The contract has an...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to the University of Chicago, a private non-profit educational institution and research university. The $278,842.39 delivery order contract is for infrastructure setup services and is not associated with any set-aside designation. The contract is a task order under a larger Cancer Study Cohort Recruitment indefinite delivery, indefinite quantity (IDIQ)...
This federal contract award, valued at $223,861.02, was issued by the National Cancer Institute (NCI) to the University of Chicago for continued infrastructure setup. The contract is a delivery order under the Cancer Study Cohort Recruitment indefinite delivery/indefinite quantity (IDIQ) contract. The University of Chicago, a renowned private research university, will provide services and support for this infrastructure work, which does not have a set-aside designation. The University of Chicago...
This is a task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the University of Chicago, a private not-for-profit university and research institution. The task order, titled "STUDY PLANNING AND PREPARATION," is part of the larger Cancer Study Cohort Recruitment indefinite-delivery, indefinite-quantity (IDIQ) contract. The task order has a potential value of $1,201,036.59 and a completion date of...
This federal contract award, valued at $28,515,413.00, was issued by the National Cancer Institute (NCI) to the University of Chicago for the "EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS" effort. The contract is a definitive contract with a cost-no-fee pricing type and does not have a set-aside designation. The University of Chicago, a renowned private research university, will conduct cutting-edge research and provide specialized services in areas critical to national...
This is a $12,000,000.00 cost-no-fee delivery order contract awarded to the University of Chicago by the National Institutes of Health (NIH) to support the Medical Imaging and Data Resource Center (MIDRC) - Medical Imaging in the Biomedical Data Fabric project. The contract has an ultimate completion date of August 20, 2027. The University of Chicago is a renowned private research university that frequently receives substantial federal funding through contracts and grants to support its research...
This is a Cost No Fee definitive contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to the University of Chicago. The contract, valued at $1,104,181.80, is for the continuation of follow-up of diethylstilbestrol (DES)-exposed cohorts. The contract does not have a set-aside designation. As a major recipient of federal research funding, the University of Chicago conducts cutting-edge research across various disciplines, often in...
This is a $12,383.56 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the University of Chicago, a private nonprofit research university. The contract is for the development of software and does not have a set-aside designation. The award is associated with a larger Other Transaction Agreement with the Defense Advanced Research Projects Agency (DARPA) focused on research into measurement-based...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $1.16 million firm fixed price purchase order to the University of Chicago. The order is for Pediatric Cancer Data Commons Harmonization services from September 1, 2020 through June 30, 2022. Per the sole source solicitation notice, the University will harmonize pediatric cancer data to facilitate analysis and research, supporting NCI's goal of integrating...
This is a definitive contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the University of Illinois for preclinical pharmacology and toxicology studies. The contract, valued at $24,207,156.38, does not have a set-aside designation. The University of Illinois, a major public research institution, is conducting research and development work to support the PREVENT Cancer Preclinical Drug Development Program, a structured...

This $11,541,930.00 delivery order contract was awarded by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to the University of Chicago. The contract supports the "PREPARATION AND STUDY LAUNCH" for a Cancer Study Cohort Recruitment effort, which is the parent indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The award has a period of performance through July 6, 2025 and does not have a set-aside designation. The University of Chicago, a renowned private research university, is the prime contractor for this effort, which likely involves conducting specialized research and providing services related to the NCI's cancer research priorities. This delivery order award is part of the university's substantial portfolio of federal research contracts and grants, which support its world-class faculty and facilities in addressing complex challenges across disciplines.

Generated 12/5/24, 10:36 AM